Hospital And Nursing Home Probiotics Forecast Report – Designed for Decision Makers and Product Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Hospital And Nursing Home Probiotics Market?
The market size for probiotics in hospitals and nursing homes has seen significant growth in the recent past. The market, which stood at $1.51 billion in 2024, is predicted to expand to $1.69 billion in 2025, with a compound annual growth rate (CAGR) of 11.81%. This growth during the historic period is attributed to a rise in gut health awareness, an increase in gastrointestinal disorders, a surge in the use of probiotics in healthcare environments, and growing proof of the health advantages of probiotics.
What Growth Rate Is Forecasted for the Hospital And Nursing Home Probiotics Market by 2029?
The market size for probiotics in hospitals and nursing homes is set to experience substantial growth over the coming years, escalating to a value of $2.61 billion in 2029 with a compound annual growth rate (CAGR) of 11.44%. This growth during the anticipated period could be due to increased usage of probiotics, burgeoning demand for solutions to digestive health issues, rising awareness about probiotics, increased emphasis on minimising hospital-acquired infections (HAIs), and increased funding in probiotic-related medical nutrition. Notable trends for the forecast period include progress in probiotic formulations, enhancements in methods of delivery for specific healthcare environments, innovative probiotic uses in preventing infections, the creation of specialized probiotics for the elderly and immunocompromised patients, and the incorporation of digital solutions.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20834&type=smp
Which Key Companies Are Shaping the Future of the Hospital And Nursing Home Probiotics Market?
Major companies operating in the hospital and nursing home probiotics market are Nestlé Health Science, BASF SE, Procter & Gamble Company, Abbott Laboratories, Lactalis Group, Danone S.A., General Mills Inc., Arla Foods Group, DuPont de Nemours Inc., Kerry Group plc, Koninklijke DSM N.V., Glanbia PLC, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., BioGaia AB, Klaire Labs, SymbioPharm GmbH, Synlogic Inc., Vitakem Nutraceuticals
Which Factors Are Driving Demand in the Hospital And Nursing Home Probiotics Industry?
The growth of the hospital and nursing home probiotics market is likely to be spurred by the escalating incidence of gastrointestinal disorders. These comprise a variety of conditions that affect the digestive system, including ailments like irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and constipation. Factors such as unhealthy eating habits, higher intake of processed foods, inactive lifestyles, and increased stress levels are contributing to the growing occurrence of these gastrointestinal disorders. Hospital and nursing home probiotics play a significant role in managing these disorders by reestablishing the equilibrium of good gut bacteria, supporting digestive health, and easing symptoms like diarrhea, constipation, and abdominal bloating. As an example, the IBD Registry, a non-profit organization based in the UK, reported that the count of individuals diagnosed with Inflammatory Bowel Disease (IBD) exceeded 5,300 in December 2023, indicating an uplift of more than 3,000 members from 2022. Consequently, the amplified prevalence of gastrointestinal disorders is propelling the expansion of the hospital and nursing home probiotics market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=20834&type=smp
How Is the Hospital And Nursing Home Probiotics Market Segmented by Several Divisions?
The hospital and nursing home probiotics market covered in this report is segmented –
1) By Indication: Antibiotic-Associated Diarrhea, Irritable Bowel Syndrome, Clostridium difficile Infection, Inflammatory Bowel Disease, General Gut Health
2) By Formulation Type: Capsules, Powder, Liquid, Soft Chew, Probiotic Yogurt
3) By Patient Group: Infants, Adults, Elderly, Immunocompromised Patients, Patients With Gastrointestinal Disorders
4) By Distribution Channel: Hospitals, Nursing Homes, Pharmacies, Online Retail, Healthcare Facilities
5) By Application: Gut Health, Immunity, Wellness, Other Applications
Subsegments:
1) By Antibiotic-Associated Diarrhea (AAD): Prevention of AAD, Treatment of AAD
2) By Irritable Bowel Syndrome (IBS): IBS With Diarrhea (IBS-D), IBS With Constipation (IBS-C), Mixed IBS (IBS-M)
3) By Clostridium Difficile Infection (CDI): Prevention of CDI Recurrence, Treatment Of CDI
4) By Inflammatory Bowel Disease (IBD): Crohn’s Disease, Ulcerative Colitis
5) By General Gut Health: Immune System Support, Digestive Health, Gut Microbiome Restoration
What are the Emerging Market Trends Driving the Growth of the Hospital And Nursing Home Probiotics Industry?
Leading enterprises in the hospital and nursing home probiotics market are prioritizing the creation of innovative products such as probiotic solutions. These solutions aim to boost patient gut health, decrease recovery times, and mitigate the side effects associated with antibiotics. Probiotic solutions are products that provide health benefits when taken in the right quantities – they typically improve the balance of beneficial bacteria in the digestive system. For example, in October 2024, Probi AB, a biotech company based in Sweden and focused on probiotics, introduced Metabolic Health by Probi specifically for healthcare environments. This is a scientifically supported probiotic solution, crafted to encourage metabolic fitness, heart health, weight management, and blood pressure regulation. It achieves this by blending two proprietary probiotic strains, namely, Lactiplantibacillus plantarum 299v (LP299V) and Lacticaseibacillus paracasei 8700:2 (L. Paracasei 8700:2).
Access The Full Report Here:
Which Regions Are Driving Growth in the Hospital And Nursing Home Probiotics Market?
North America was the largest region in the hospital and nursing home probiotics market in 2024. The regions covered in the hospital and nursing home probiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20834
This Report Delivers Insight On:
1. How big is the hospital and nursing home probiotics market, and how is it changing globally?
2. Who are the major companies in the hospital and nursing home probiotics market, and how are they performing?
3. What are the key opportunities and risks in the hospital and nursing home probiotics market right now?
4. Which products or customer segments are growing the most in the hospital and nursing home probiotics market?
5. What factors are helping or slowing down the growth of the hospital and nursing home probiotics market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
